Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis

BACKGROUND: Anti-glycan antibodies can be found in autoimmune diseases. IgM against glycan P63 was identified in clinically isolated syndromes (CIS) and included in gMS-Classifier2, an algorithm designed with the aim of identifying patients at risk of a second demyelinating attack. OBJECTIVE: To det...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrambide, Georgina, Espejo, Carmen, Yarden, Jennifer, Fire, Ella, Spector, Larissa, Dotan, Nir, Dukler, Avinoam, Rovira, Alex, Montalban, Xavier, Tintore, Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610690/
https://www.ncbi.nlm.nih.gov/pubmed/23555846
http://dx.doi.org/10.1371/journal.pone.0059953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610690/
https://www.ncbi.nlm.nih.gov/pubmed/23555846
http://dx.doi.org/10.1371/journal.pone.0059953

Ejemplares similares